A new strategy for T cell therapy: T cells secreting TCR anti-CD3 bispecific T-cell engager

被引：0
|
作者：
Sun, Hanli
Huang, Jiao
Zhan, Kai
Wu, Wanli
Tang, Xianqing
Liu, Min
Guo, Shanshan
Zheng, Hongjun
Huang, Yingjie
Zhong, Shi
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3598
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3598
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma
    Sangsuwannukul, Thanich
    Supimon, Kamonlapat
    Chieochansin, Thaweesak
    Choomee, Kornkan
    Sujjitjoon, Jatuporn
    Junking, Mutita
    Yenchitsomanus, Pa-Thai
    PLOS ONE, 2022, 17 (03):
  • [2] THE ROLE OF T-CELL ACTIVATION IN ANTI-CD3 X ANTITUMOR BISPECIFIC ANTIBODY THERAPY
    WEINER, GJ
    KOSTELNY, SA
    HILLSTROM, JR
    COLE, MS
    LINK, BK
    WANG, SL
    TSO, JY
    JOURNAL OF IMMUNOLOGY, 1994, 152 (05): : 2385 - 2392
  • [3] The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers
    van Diest, Eline
    Nicolasen, Mara J. T.
    Kramer, Lovro
    Zheng, Jiali
    Hernandez-Lopez, Patricia
    Beringer, Dennis X.
    Kuball, Jurgen
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [4] TGF-β, T-cell tolerance and anti-CD3 therapy
    Bommireddy, R
    Doetschman, T
    TRENDS IN MOLECULAR MEDICINE, 2004, 10 (01) : 3 - 9
  • [5] Tetracyclines Enhance Anti-tumor T-Cell Responses Induced by a Bispecific T-Cell Engager
    Noguchi, Yuki
    Yamamoto, Yoko
    Iwahori, Kota
    Matsumoto, Mitsunobu
    Hirata, Michinari
    Okuyama, Hiroomi
    Shintani, Yasushi
    Kumanogoh, Atsushi
    Wada, Hisashi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (04) : 429 - 437
  • [6] Cardiovascular toxicities associated with bispecific T-cell engager therapy
    Sayed, Ahmed
    Munir, Malak
    Ghazi, Sanam M.
    Ferdousi, Mussammat
    Krishan, Satyam
    Shaaban, Adnan
    Habib, Alma
    Kola-Kehinde, Onaopepo
    Ruz, Patrick
    Khan, Sarah
    Sharma, Sneha
    Meara, Alexa
    Mahmood, Syed
    Feldman, Stephanie
    Yang, Eric H.
    Kim, Jiwon
    Epperla, Narendranath
    Addison, Daniel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (02)
  • [7] Safety of Bispecific T-cell Engager Therapy in Autoimmune Disease
    Hagen, Melanie
    Bucci, Laura
    Boeltz, Sebastian
    Noethling, Danae-Mona
    Rothe, Tobias
    Raimondo, Maria Gabriella
    Tur, Carlo
    Wirsching, Andreas
    Wacker, Jochen
    Bozec, Aline
    Schett, Georg
    Grieshaber-Bouyer, Ricardo
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2299 - 2300
  • [8] Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study
    Subklewe, Marion
    Magno, Giulia
    Gebhardt, Christina
    Buecklein, Veit
    Szelinski, Franziska
    Arevalo, Hector Julian Rincon
    Haenel, Gerulf
    Doerner, Thomas
    Zugmaier, Gerhard
    von Bergwelt-Baildon, Michael
    Skapenko, Alla
    Schulze-Koops, Hendrik
    EUROPEAN JOURNAL OF CANCER, 2024, 204
  • [9] T-cell Immunotherapy and Cardiovascular Disease Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies
    Stein-Merlob, Ashley F.
    Ganatra, Sarju
    Yang, Eric H.
    HEART FAILURE CLINICS, 2022, 18 (03) : 443 - 454
  • [10] Mechanisms of resistance to bispecific T-cell engager therapy for ovarian cancer
    Barakzai, Syem
    Xu, Mengyao
    Veillard, Irva
    Matoba, Yusuke
    Kononenko, Artem
    Kim, Eugene
    Bregar, Amy
    Eisenhauer, Eric L.
    Penson, Richard T.
    Bouberhan, Sara
    Colella, Tina
    Clark, Caroline
    Castro, Cesar Martin
    Spriggs, David R.
    Rueda, Bo R.
    Yeku, Oladapo O.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345